Company intelligence / Profile preview

Sonoma Pharmaceuticals, Inc.

Boulder, Colorado, United Statessonomapharma.com ↗

Ownership: Public · SNOA
Employees: ~172
Development stage: Commercial

Overview

Sonoma Pharmaceuticals develops and produces stabilized hypochlorous acid (HOCl) products for various applications including wound care, dermatology, animal health care, and non-toxic disinfectants. Their products are clinically proven to reduce itch, pain, scarring, and irritation safely without damaging healthy tissue.

Therapeutic areas: OtherOphthalmologyDermatology
Modalities: Hypochlorous acid (HOCl) based products
Industry: Biotech

Drug pipeline

16 assets

hypochlorous acid

15 more assets in the full pipeline.

Request access →

Partnerships

MicroSafe

Financials

Market cap: $2.2M
Total revenue: $6.4M
Enterprise value: $-2.4M

Beyond the preview

Go deeper on Sonoma Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonoma Pharmaceuticals, Inc..

Explore the full profile